Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 4 | 40 | 9 | 10 |
| Receivables | N/A | 2 | 1 | 3 | 3 |
| Inventories | N/A | 10 | 60 | 110 | 70 |
| Other current assets | 0 | 14 | 19 | 48 | 27 |
| TOTAL | $N/A | $30 | $120 | $170 | $110 |
| Non-Current Assets | |||||
| PPE Net | N/A | 30 | 60 | 100 | 120 |
| Other Non-Current Assets | 0 | 7,149 | 7,620 | 8,680 | 9,430 |
| TOTAL | $N/A | $7,179 | $7,680 | $8,780 | $9,550 |
| Total Assets | $N/A | $7,220 | $7,820 | $8,970 | $9,680 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 1,070 | 400 | 310 | 640 |
| Accrued Expenses | N/A | 1,530 | 520 | 840 | 380 |
| Other current liabilities | N/A | 9 | 0 | 20 | 10 |
| TOTAL | $N/A | $6,740 | $6,300 | $3,660 | $1,300 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 2,830 | 2,830 | 2,830 | 2,260 |
| TOTAL | $N/A | $2,830 | $2,830 | $2,830 | $2,260 |
| Total Liabilities | $N/A | $9,580 | $9,130 | $6,500 | $3,570 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 22,870 | 17,260 | 16,300 | 16,290 |
| Retained earnings | N/A | -28,930 | -22,350 | -17,380 | -13,040 |
| Other shareholders' equity | 0 | -100 | -20 | 40 | -670 |
| TOTAL | $N/A | $-2,360 | $-1,310 | $2,460 | $6,110 |
| Total Liabilities And Equity | $0 | $7,220 | $7,820 | $8,960 | $9,680 |